help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crippes, B. A.
Right arrow Articles by Nickols, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crippes, B. A.
Right arrow Articles by Nickols, G. A.

Endocrinology, Vol 137, 918-924, Copyright © 1996 by Endocrine Society


ARTICLES

Antibody to beta3 integrin inhibits osteoclast-mediated bone resorption in the thyroparathyroidectomized rat

BA Crippes, VW Engleman, SL Settle, J Delarco, RL Ornberg, MH Helfrich, MA Horton and GA Nickols
Department of Molecular Pharmacology, Searle, St. Louis, Missouri 63301, USA.

The cell surface integrin, alphaVbeta3, is important for the attachment of osteoclasts to bone matrix and the subsequent resorption of bone. The present study was designed to determine the effects of F11, a monoclonal antibody to the rat beta3 subunit, on calcium mobilization in a rat model of bone resorption. Male Sprague Dawley rats became hypocalcemic within 18 h after thyroparathyroidectomy. Synthetic PTH- related protein (PTHrP(1-34)) administered to control rats caused serum calcium to return to normal. Anti-beta3 treatment of rats after thyroparathyroidectomy inhibited the calcemic response to PTHrP by 65%. Circulating F11 was biologically active as demonstrated by osteoclast retraction and by the inhibition of adenosine diphosphate-induced platelet aggregation via inhibition of the platelet integrin alphaIIbbeta3 in ex vivo assays. F11 antibody was localized by immunohistological staining to osteoclasts in long bones, suggesting that the mechanism of action of the antibody was via a direct effect upon osteoclasts. Echistatin and calcitonin also inhibited calcemic responses to PTHrP in this in vivo model, whereas an isotype-matched, control antibody was ineffective. These studies provide the first direct evidence in vivo that osteoclast-mediated bone resorption is regulated via beta3 integrin.


This article has been cited by other articles:


Home page
JNMHome page
J. E. Sprague, H. Kitaura, W. Zou, Y. Ye, S. Achilefu, K. N. Weilbaecher, S. L. Teitelbaum, and C. J. Anderson
Noninvasive Imaging of Osteoclasts in Parathyroid Hormone-Induced Osteolysis Using a 64Cu-Labeled RGD Peptide
J. Nucl. Med., February 1, 2007; 48(2): 311 - 318.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. J. Hoffman, J. Vasko-Moser, W. H. Miller, M. W. Lark, M. Gowen, and G. Stroup
Rapid Inhibition of Thyroxine-Induced Bone Resorption in the Rat by an Orally Active Vitronectin Receptor Antagonist
J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 205 - 211.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. C. D'Alonzo, A. J. Kowalski, D. T. Denhardt, G. A. Nickols, and N. C. Partridge
Regulation of Collagenase-3 and Osteocalcin Gene Expression by Collagen and Osteopontin in Differentiating MC3T3-E1 Cells
J. Biol. Chem., June 28, 2002; 277(27): 24788 - 24798.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Inoue, F. P. Ross, J. M. Erdmann, Y. Abu-Amer, S. Wei, and S. L. Teitelbaum
Tumor Necrosis Factor {alpha} Regulates {alpha}v{beta}5 Integrin Expression by Osteoclast Precursors in Vitro and in Vivo
Endocrinology, January 1, 2000; 141(1): 284 - 290.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. W. Lark, G. B. Stroup, S. M. Hwang, I. E. James, D. J. Rieman, F. H. Drake, J. N. Bradbeer, A. Mathur, K. F. Erhard, K. A. Newlander, et al.
Design and Characterization of Orally Active Arg-Gly-Asp Peptidomimetic Vitronectin Receptor Antagonist SB 265123 for Prevention of Bone Loss in Osteoporosis
J. Pharmacol. Exp. Ther., November 1, 1999; 291(2): 612 - 617.
[Abstract] [Full Text]


Home page
J. Exp. Med.Home page
S. C. Finnemann and E. Rodriguez-Boulan
Macrophage and Retinal Pigment Epithelium Phagocytosis: Apoptotic Cells and Photoreceptors Compete for {alpha}v{beta}3 and {alpha}v{beta}5 Integrins, and Protein Kinase C Regulates {alpha}v{beta}5 Binding and Cytoskeletal Linkage
J. Exp. Med., September 20, 1999; 190(6): 861 - 874.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Yoshitake, S. R. Rittling, D. T. Denhardt, and M. Noda
Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption
PNAS, July 6, 1999; 96(14): 8156 - 8160.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
I Nakamura, M. Pilkington, P. Lakkakorpi, L Lipfert, S. Sims, S. Dixon, G. Rodan, and L. Duong
Role of alpha(v)beta(3) integrin in osteoclast migration and formation of the sealing zone
J. Cell Sci., January 11, 1999; 112(22): 3985 - 3993.
[Abstract] [PDF]


Home page
EndocrinologyHome page
M. Yamamoto, J. E. Fisher, M. Gentile, J. G. Seedor, C.-T. Leu, S. B. Rodan, and G. A. Rodan
The Integrin Ligand Echistatin Prevents Bone Loss in Ovariectomized Mice and Rats
Endocrinology, March 1, 1998; 139(3): 1411 - 1419.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. G. Erben, S. Raith, J. Eberle, and M. Stangassinger
Ovariectomy augments B lymphopoiesis and generation of monocyte-macrophage precursors in rat bone marrow
Am J Physiol Endocrinol Metab, March 1, 1998; 274(3): E476 - E483.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. T. Duong, I. Nakamura, P. T. Lakkakorpi, L. Lipfert, A. J. Bett, and G. A. Rodan
Inhibition of Osteoclast Function by Adenovirus Expressing Antisense Protein-tyrosine Kinase 2
J. Biol. Chem., March 2, 2001; 276(10): 7484 - 7492.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society